Assured Pharmacy – APHY – Stock Guru Profile
Everyone wins! In serving the under-served chronic pain marke,t Assured Pharmacy creates a situation that is beneficial to the patient, the physician, and society! In a nutshell here is what Assured Pharmacy is offering in the chronic pain prescription market and intends to offer nationwide:
CHRONIC PAIN – Under-served Expanding Market
Benefits to the Physician
- – Free electronic prescribing provides patient history at a glance
- – Customized patient/DEA/drug reports
- – Eliminates calls from pharmacists due to illegible handwriting
- – Provide check for drug/food interactions and allergies
- – Minimize errors due to “look alike” and “sound alike” medications
- – Diligent, professional, available pharmacists
Benefits to the Assured Client
- – Free home delivery; no more paper prescriptions
- – Fast; no more waiting in lines
- – Low cost prescriptions
- – Availability of difficult to obtain C2 and C3 medications
- – Friendly, caring staff
Extreme Focus on Customer
- – Monthly calls to check-in, and to provide refill assistance
- – All store personnel given financial incentive to meet monthly sale goals
- – A relationship pharmacy, we get to know our customers
Excellent Value Proposition
Topical Compounding
- – Enables chronic pain patients to better manage their medications
- – Not transdermal, so it doesn’t interfere with medications being taken
- – Quality product offering with high profit margins
This company DOES NOT compete with Wal-Mart! This company fills a void in patient and physician pharmacy needs! Their success is reflected in expanding sales!
Stay tuned to understand why specialized pharmacies appeal to physicians who treat patients with chronic pain.
Source: APHY
Assured Pharmacy
17935 Sky Park Circle, Ste. F
Irvine, CA 92614
Phone: (949) 222-9971
Fax: (949) 222-0978
Investor Relations:
Andrew Brown
ROI Group LLC
212-495-0202
abrown@roiny.com
About Assured Pharmacy: Assured Pharmacy provides customized services for patients with and physicians treating chronic pain, including specialized expertise in dispensing pain medication, including Class II substances, streamlined prescription processes, digital prescribing technologies, and specialty drug compounding services. APHY also offers a complete line of durable medical equipment through its DME division. APHY currently operates retail sites in Portland, Oregon (three), Santa Ana and Riverside, California, and Kirkland, Washington. More information about APHY is available at http://www.assuredpharmacy.com.
Forward Looking Statements: Certain statements in this news release may constitute “forward-looking” statements within the meaning of section 21E of the Securities and Exchange Act of 1934. The Company believes that its expectations, as expressed in these statements are based on reasonable assumptions regarding the risks and uncertainties inherent in achieving those expectations. These statements are not, however, guarantees of future performance and actual results may differ materially. Some of the factors that may affect the forward looking statements in this news release are the availability of licensed personnel to operate pharmacies, the availability of suitable pharmacy locations, and the acceptance of new technologies by the medical profession. Other risk factors are listed in the most recent Annual Report on Form 10-KSB, Quarterly Report on Form 10-QSB, and most recent Registration Statement on Form SB-2 filed with the Securities and Exchange Commission. Such forward-looking statements involve risks, uncertainties, which may cause the actual results, performance, or achievement expressed or implied to differ.
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (469) 252-3030. Web: StockGuru.com. Email: Publisher@stockguru.com.
Disclosure: Pentony Enterprises LLC has been compensated $10,000 directly from the company for profile coverage. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.